Skip to main content
Clinical Trials/NCT01040273
NCT01040273
Unknown
Phase 2

Management of Postoperative Pain After Total Hip Arthroplasty

Chang Gung Memorial Hospital1 site in 1 countryDecember 2009

Overview

Phase
Phase 2
Intervention
Bupivacaine
Conditions
Osteoarthritis of Hip
Sponsor
Chang Gung Memorial Hospital
Locations
1
Primary Endpoint
Pain VAS score
Last Updated
16 years ago

Overview

Brief Summary

Orthopedic surgery is reportedly among the most painful surgical procedures. Surgical damage following major orthopedic surgery often involves a large, deep incision with considerable tissue dissection and muscle, bone, and vascular exposure. Post-operative pain after such surgery is exacerbated on movement or by reflex spasms of the muscles, which may delay mobilization, reduce satisfaction, prolong hospitalization, and possibly increase medical costs.

We design a prospective randomized study for postoperative pain control following total hip arthroplasty.

Registry
clinicaltrials.gov
Start Date
December 2009
End Date
December 2010
Last Updated
16 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Chang Gung Memorial Hospital

Eligibility Criteria

Inclusion Criteria

  • diagnosed for surgery of osteoarthritis of hip
  • ability to tolerate surgery under general anesthesia.

Exclusion Criteria

  • refusal or the lack of mental ability to provide informed consent
  • neuropathic pain or sensory disorders in the leg requiring surgery
  • previous surgery of the hip joint
  • coagulation abnormalities
  • severe renal or hepatic impairment
  • chronic opioid users
  • known history of intolerance to the drugs used in the study

Arms & Interventions

Experiment

Anesthetics intraarticular injection

Intervention: Bupivacaine

Placebo

saline intraarticular injection

Intervention: Placebo

Outcomes

Primary Outcomes

Pain VAS score

Time Frame: pre-operaton, immediately post operation, postop 6hrs, postop 12hrs, postop 18hrs, postop 24hrs, post op 48hrs, postop 72hrs

Secondary Outcomes

  • Functional score: WOMAC hip score, SF-36(Pre-operation, immediately post-operation, postop 6 weeks, postop 12 weeks)

Study Sites (1)

Loading locations...

Similar Trials